Globalpharma, a subsidiary of Dubai Investments Industries (DII) and a leading player in the regional pharmaceutical industry, will unveil its latest products at the Duphat 2009.

The three-day exhibition will witness Globalpharma present an overview of breakthrough products set for imminent launch.

The company will present its new range of products including antihypertensives and pain relievers, as well as a new weight loss product that will be launched in regional markets in April 2009.

“As the largest annual exhibition for the region’s pharmaceutical industry, Duphat offers us unparalleled brand visibility and excellent networking possibilities,” said Jamil Akhtar, general manager of Globalpharma.

This is Globalpharma's third consecutive year at Duphat. “The event attracts the biggest names from the pharma industry and brings together key regional decision-makers, giving us an opportunity to explore strategic alliances and reinforce our relationship with health ministries and regulatory authorities from the UAE and other regional countries,” he added.

“While the global financial crisis has left virtually no economic sector completely untouched, pharmaceutical remains one of the least affected industries, and this is especially true of the pharmaceutical market in the Middle East, where analysts forecast massive, sustained growth over the next few years.

Liberalization of domestic economies, combined with strong governmental efforts to encourage indigenous manufacture of pharmaceutical products, have been key growth drivers for Middle East’s pharma industry,” Akhtar added.

Globalpharma is Dubai’s first pharmaceutical manufacturing company, manufacturing and marketing pharmaceutical products in more than 20 countries across the Middle East, Africa and Far East.

Established in 1998, the company has developed into a major player in the MEA pharmaceutical market, earning a reputation for quality and reliability.-TradeArabia News Service